Guantanamo.- In the next few days, the El Salvador Municipality, in Guantanamo Province, will join its counterparts in the province that are implementing an immunization scheme starting next September 9, which administeres the Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed, 10-Valent), for infants under two months old.
Maidolis Brooks, vaccination advisor in the mountainous territory, specified that the application of the immunogen aims to reduce pneumococcal diseases caused by the Streptococcus pneumoniae bacteria, also known as pneumococcus.
The pneumococcus bacteria can cause serious invasive diseases, such as acute meningitis, pneumonia and sepsis.
Symptoms of the pathology include sudden fever, nausea, vomiting, intense headache, altered mental status, stiff neck and photophobia. Other signs are difficulty breathing, cough, fever, chest pain and fatigue.
Pneumococcus is the second most common cause of community-acquired pneumonia requiring hospitalization, after Respiratory Syncytial Virus, in both adults and children.
Translated by Liubis Balart
